XOMAP
XOMA Royalty Corp
Key Financials
Operating Income
$11.4M
↑ 128.5%
Net Income
$31.7M
↑ 329.4%
Revenue
$52.1M
↑ 83.1%
EPS (Diluted)
$1.46
↑ 188.5%
Total Assets
$272.7M
↑ 23.2%
Total Liabilities
$168.7M
↑ 21.1%
Cash & Equivalents
$82.9M
↓ 18.4%
Shareholders' Equity
$83.9M
↑ 2.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 6/12/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| DEFM14A | 6/10/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 425 | 5/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XOMAP |
| Company Name | XOMA Royalty Corp |
| CIK | 791908 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 510-204-7239 |